LYON, France, Sept. 23, 2009 (GLOBE NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of an intensified communication and education strategy in France, aimed at increasing physician and patient awareness of Ablatherm-HIFU as a therapeutic option for localized prostate cancer.
